Clinical Trials
All Clinical Trials - Page 1 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07586150N/ANot Yet Recruiting
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Semaglutide
- NCT07382375N/ANot Yet Recruiting
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Thymosin-Alpha-1
- NCT07614412Phase 2Not Yet Recruiting
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Semaglutide
- NCT06180616Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Tirzepatide
- NCT07468552Phase 2Not Yet Recruiting
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07609160N/ANot Yet Recruiting
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Tirzepatide
- NCT07027969Phase 4Not Yet Recruiting
Metabolic Surgery for Atrial Fibrillation Elimination
Tirzepatide
- NCT07677891Phase 2Not Yet Recruiting
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
Dulaglutide
- NCT07642635Phase 1/Phase 2Not Yet Recruiting
Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
Semaglutide
- NCT07622810Phase 3Not Yet Recruiting
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
Semaglutide
- NCT07617155Phase 4Not Yet Recruiting
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
Semaglutide
- NCT07509112Phase 2Not Yet Recruiting
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Semaglutide
- NCT07668336Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Dulaglutide
- NCT07357740Phase 2Not Yet Recruiting
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
Semaglutide
- NCT06732245Phase 2Not Yet Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Tirzepatide
- NCT07282613Phase 3Not Yet Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Semaglutide
- NCT07671248Phase 3Not Yet Recruiting
Tirzepatide in the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07676331Phase 2Not Yet Recruiting
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Tirzepatide
- NCT07630454Phase 4Not Yet Recruiting
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
Tirzepatide
- NCT07592546Phase 4Not Yet Recruiting
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Semaglutide
- NCT07466498Phase 2Not Yet Recruiting
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Gonadorelin
- NCT07653282Phase 1/Phase 2Not Yet Recruiting
Effect of GnRH Agonist in FET
Gonadorelin
- NCT07668765N/ANot Yet Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Tirzepatide
- NCT07671391Phase 2Not Yet Recruiting
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
Tirzepatide
- NCT07298915Phase 3Not Yet Recruiting
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
Tirzepatide
- NCT07078838Phase 2Not Yet Recruiting
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
Tirzepatide
- NCT07653477Phase 3Not Yet Recruiting
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
Semaglutide
- NCT07588438Phase 4Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Tirzepatide
- NCT07349641Phase 2Not Yet Recruiting
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
Tirzepatide
- NCT07635953Phase 3Not Yet Recruiting
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT06820281Phase 2Not Yet Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Tirzepatide
- NCT07622992N/ANot Yet Recruiting
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
Tirzepatide
- NCT07265752Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07478653N/ANot Yet Recruiting
MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
Semaglutide
- NCT07218354Phase 3Not Yet Recruiting
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder
Semaglutide
- NCT07636239N/ANot Yet Recruiting
Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery
Ghrp-6
- NCT07573163Phase 2Not Yet Recruiting
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide
- NCT07563699Phase 1/Phase 2Not Yet Recruiting
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Semaglutide
- NCT07411378Phase 2Not Yet Recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
Semaglutide
- NCT07457164Phase 2Not Yet Recruiting
A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT07654062Phase 4Not Yet Recruiting
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
Mazdutide
- NCT07613307Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Orforglipron
- NCT07511543Phase 2Not Yet Recruiting
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
Semaglutide
- NCT07627191EARLY_Phase 1Not Yet Recruiting
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Semaglutide
- NCT07531251Phase 4Not Yet Recruiting
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Elamipretide
- NCT07310420Phase 1Recruiting
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
Gonadorelin
- NCT06913075N/ANot Yet Recruiting
FET in Adenomyosis
Gonadorelin
- NCT07668388Phase 2Not Yet Recruiting
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Semaglutide
- NCT07357766Phase 3Not Yet Recruiting
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Semaglutide
- NCT07382024N/ANot Yet Recruiting
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Tirzepatide